Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
Details for Australian Patent Application No. 2002246738 (hide)
Event Publications
23 January 2003 Application Open to Public Inspection
Published as AU-A-2002246738
4 December 2003 Change of Name(s) of Applicant(s), Section 104
Bio-Technology General Corp. The name of the applicant has been changed to Savient Pharmaceuticals, Inc. Change of Name(s) of Applicant(s), Section 104
21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002246739-MELT POLYCARBONATE CATALYST SYSTEMS
2002246737-Specific human antibodies for selective cancer therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser